What's Happening?
Amgen is offering an undergraduate internship for Summer 2027 within its Research & Development Execution, Operations & Strategy (R&D EOS) organization. This 12-week program, based in the United States, is designed for students to gain project-based and
experiential learning. Interns will be integral members of the R&D EOS team, which focuses on driving innovation beyond the molecule and applying digital strategies to streamline processes. The R&D EOS organization encompasses four functional areas: Strategy, Portfolio & Program Management, R&D Business Operations, and R&D Knowledge & Learning. Interns will be responsible for key projects that advance the R&D EOS mission, including developing project charters, conducting qualitative and quantitative analysis, and presenting findings to executive management. Eligibility requires applicants to be 18 years or older, currently enrolled in a full-time Bachelor’s Degree program with a minimum 3.0 GPA, and expected to complete one year of study before the internship and continue enrollment afterward. The internship pays $28.87 per hour.
Why It's Important?
This internship program is significant for several reasons. For Amgen, it represents an investment in future talent, allowing the company to identify and cultivate promising individuals who can contribute to its mission of serving patients. By engaging undergraduates in R&D EOS, Amgen can infuse fresh perspectives and digital-first thinking into its operational strategies, potentially leading to more efficient drug development and delivery. For students, it offers a crucial opportunity to gain real-world experience in the biotechnology and pharmaceutical industry, a sector vital to public health and economic growth. The program's focus on strategy, operations, and digital transformation aligns with current industry trends, preparing interns for careers in a rapidly evolving landscape. Furthermore, the competitive pay and networking opportunities can provide a significant advantage for participants entering the job market, fostering a pipeline of skilled professionals for the U.S. healthcare and biotech sectors.
What's Next?
Amgen will continue accepting applications for the Summer 2027 R&D EOS internship until a sufficient number of candidates are received or a selection is made. Prospective interns will undergo an application and selection process, with successful candidates commencing their 12-week program in the summer of 2027. During the internship, participants will engage in various learning activities, networking events, and community volunteer projects. Their work will culminate in presentations to executive management, providing them with valuable exposure and feedback. The experience gained by these interns could lead to future career opportunities within Amgen or other companies in the biotechnology and pharmaceutical industries, contributing to the long-term talent pool for these critical sectors in the U.S.
Beyond the Headlines
The Amgen R&D EOS internship highlights a broader trend in the pharmaceutical industry: the increasing emphasis on operational efficiency and digital transformation in research and development. Beyond the scientific breakthroughs, the ability to strategically manage portfolios, optimize business operations, and leverage digital tools is becoming paramount for bringing medicines to patients faster. This internship, by focusing on these areas, underscores the evolving skill sets required in modern biotech. It also reflects the industry's commitment to fostering diversity and inclusion, as Amgen emphasizes an inclusive environment and provides reasonable accommodations for individuals with disabilities. Such programs are crucial for ensuring a diverse and skilled workforce that can address complex global health challenges, while also promoting equitable access to career opportunities in high-growth sectors.













